BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carr DJJ, Gmyrek GB, Filiberti A, Berube AN, Browne WP, Gudgel BM, Sjoelund VH. Distinguishing Features of High- and Low-Dose Vaccine against Ocular HSV-1 Infection Correlates with Recognition of Specific HSV-1-Encoded Proteins. Immunohorizons 2020;4:608-26. [PMID: 33037098 DOI: 10.4049/immunohorizons.2000060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Gmyrek GB, Berube AN, Sjoelund VH, Carr DJJ. HSV-1 0∆NLS vaccine elicits a robust B lymphocyte response and preserves vision without HSV-1 glycoprotein M or thymidine kinase recognition. Sci Rep 2022;12:15920. [PMID: 36151255 DOI: 10.1038/s41598-022-20180-0] [Reference Citation Analysis]
2 Nabi R, Lewin AC, Collantes TM, Chouljenko VN, Kousoulas KG. Intramuscular Vaccination With the HSV-1(VC2) Live-Attenuated Vaccine Strain Confers Protection Against Viral Ocular Immunopathogenesis Associated With γδT Cell Intracorneal Infiltration. Front Immunol 2021;12:789454. [PMID: 34868077 DOI: 10.3389/fimmu.2021.789454] [Reference Citation Analysis]
3 Carr DJJ, Berube A, Gershburg E. The Durability of Vaccine Efficacy against Ocular HSV-1 Infection Using ICP0 Mutants 0∆NLS and 0∆RING Is Lost over Time. Pathogens 2021;10:1470. [PMID: 34832625 DOI: 10.3390/pathogens10111470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Nowińska A. Recent Advances in the Diagnosis and Management of Herpetic Keratitis. Infectious Eye Diseases - Recent Advances in Diagnosis and Treatment 2021. [DOI: 10.5772/intechopen.96898] [Reference Citation Analysis]
5 Stanfield BA, Kousoulas KG, Fernandez A, Gershburg E. Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses. Viruses 2021;13:1637. [PMID: 34452501 DOI: 10.3390/v13081637] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
6 Carr DJJ, Berube AN, Filiberti A, Gmyrek GB. Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0ΔNLS vaccine against ocular HSV-1 challenge. Vaccine 2021;39:2526-36. [PMID: 33814229 DOI: 10.1016/j.vaccine.2021.03.075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]